New hope for rare blood disorder: Half-Matched transplants show promise
NCT ID NCT02828592
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people with severe aplastic anemia, a rare condition where the bone marrow stops making enough blood cells, leading to serious infections and bleeding. It tests a bone marrow transplant from a half-matched family donor, followed by a drug to reduce complications. The goal is to see if this approach can safely restore normal blood cell production in patients who don't have a fully matched donor.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE APLASTIC ANEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Blood and Marrow Transplant Group of Georgia
RECRUITINGAtlanta, Georgia, 30342, United States
-
Northside Hospital
RECRUITINGAtlanta, Georgia, 30342, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentler chemo-radiation combo make stem cell transplants safer for blood cancers?
- Half-Matched stem cell transplant offers hope for children with blood disorders
- New transplant approach aims to tame bone marrow failure
- New hope for older adults with rare blood disorder: safer transplant regimen under study
- New drug combo shows promise for rare bone marrow failure
- New drug combo shows promise for rare blood disorder